|
"楊志新"的相關文件
顯示項目 11-60 / 209 (共5頁)
1 2 3 4 5 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T15:17:53Z |
Treating patients with ALK -positive non-small cell lung cancer: Latest evidence and management strategy
|
Liao, B.-C. and Lin, C.-C. and Shih, J.-Y. and Yang, J.C.-H.; Liao, Bin-Chi;Lin, Chia-Chi;Shih, Jin-Yuan;Yang, James Chih-Hsin; 林家齊;楊志新;廖斌志;施金元; 林家齊;楊志新;廖斌志;施金元; Liao, Bin-Chi; Lin, Chia-Chi; Shih, Jin-Yuan; Yang, James Chih-Hsin |
| 臺大學術典藏 |
2018-09-10T15:17:53Z |
Rapid Response to Sunitinib in a Patient with Lung Adenocarcinoma Harboring KIF5B-RET Fusion Gene
|
Wu, H. and Shih, J.-Y. and Yang, J.C.-H.; Wu, Hsu;Shih, Jin-Yuan;Yang, James Chih-Hsin; Wu, Hsu;Shih, Jin-Yuan;Yang, James Chih-Hsin; 楊志新;施金元; Wu, Hsu; JIN-YUAN SHIH; Shih, Jin-Yuan; Shih, Jin-Yuan; Yang, James Chih-Hsin; Yang, James Chih-Hsin |
| 臺大學術典藏 |
2018-09-10T15:17:38Z |
High Prevalence of the BIM Deletion Polymorphism in Young Female Breast Cancer in an East Asian Country
|
Chen, Wei-Wu; Chen, I-Chun; Wu, Pei-Fang; Wu, Pei-Fang; Kuo, Sung-Hsin; Kuo, Sung-Hsin; Chen, Chien-Jen; Chen, Chien-Jen; Lu, Yen-Shen; Lu, Yen-Shen; Cheng, Ann-Lii; Lin, Ching-Hung;Shen, Chen-Yang;Lee, Jih-Hsiang;Huang, Chiun-Sheng;Yang, Chih-Hsin;Kuo, Wen-Hung;Chang, Dwan-Ying;Hsiung, Chia-Ni;Kuo, Kuan-Ting;Chen, Wei-Wu;Chen, I-Chun;Wu, Pei-Fang;Kuo, Sung-Hsin;Chen, Chien-Jen;Lu, Yen-Shen;Cheng, Ann-Lii; Lin, Ching-Hung;Shen, Chen-Yang;Lee, Jih-Hsiang;Huang, Chiun-Sheng;Yang, Chih-Hsin;Kuo, Wen-Hung;Chang, Dwan-Ying;Hsiung, Chia-Ni;Kuo, Kuan-Ting;Chen, Wei-Wu;Chen, I-Chun;Wu, Pei-Fang;Kuo, Sung-Hsin;Chen, Chien-Jen;Lu, Yen-Shen;Cheng, Ann-Lii; Ching-Hung Lin and Chen-Yang Shen and Jih-Hsiang Lee and Chiun-Sheng Huang and Chih-Hsin Yang and Wen-Hung Kuo and Dwan-Ying Chang and Chia-Ni Hsiung and Kuan-Ting Kuo and Wei-Wu Chen and I-Chun Chen and Pei-Fang Wu and Sung-Hsin Kuo and Chien-Jen Chen and Yen-Shen Lu and Ann-Lii Cheng; 林志弘;楊志新;陳偉武;郭文宏;盧彥伸;林璟宏;陳怡君;郭冠廷;郭頌鑫;吳佩芳;鄭安理;黃俊升;張端瑩;李日翔;林季宏; 林志弘;楊志新;陳偉武;郭文宏;盧彥伸;林璟宏;陳怡君;郭冠廷;郭頌鑫;吳佩芳;鄭安理;黃俊升;張端瑩;李日翔;林季宏; Lin, Ching-Hung; Lin, Ching-Hung; CHIUN-SHENG HUANG; Sung-Hsin Kuo; Shen, Chen-Yang; Chiang, I-Ni; CHING-HUNG LIN; Lee, Jih-Hsiang; Lee, Jih-Hsiang; Huang, Chiun-Sheng; KUAN-TING KUO; Huang, Chiun-Sheng; Yang, Chih-Hsin; ANN-LII CHENG; Yang, Chih-Hsin; Kuo, Wen-Hung; Kuo, Wen-Hung; Chang, Dwan-Ying; Chang, Dwan-Ying; Hsiung, Chia-Ni; Hsiung, Chia-Ni; Kuo, Kuan-Ting; Kuo, Kuan-Ting; Chen, Wei-Wu |
| 臺大學術典藏 |
2018-09-10T15:17:32Z |
Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion
|
Tsai, Tzu-Hsiu;Wu, Shang-Gin;Hsieh, Min-Shu;Yu, Chong-Jen;Yang, James Chih-Hsin;Shih, Jin-Yuan; Tsai, Tzu-Hsiu;Wu, Shang-Gin;Hsieh, Min-Shu;Yu, Chong-Jen;Yang, James Chih-Hsin;Shih, Jin-Yuan; Tsai, T.-H. and Wu, S.-G. and Hsieh, M.-S. and Yu, C.-J. and Yang, J.C.H. and Shih, J.-Y.; 楊志新;余忠仁;謝明書;吳尚俊;蔡子修;施金元; MIN-SHU HSIEH; Tsai, Tzu-Hsiu; CHONG-JEN YU; Wu, Shang-Gin; Hsieh, Min-Shu; JIN-YUAN SHIH; Hsieh, Min-Shu; Yu, Chong-Jen; CHIH-HSIN YANG; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, James Chih-Hsin; Shih, Jin-Yuan; Shih, Jin-Yuan |
| 臺大學術典藏 |
2018-09-10T14:49:59Z |
Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations
|
Chen, Yen-Fu;Hsieh, Min-Shu;Wu, Shang-Gin;Chang, Yih-Leong;Shih, Jin-Yuan;Liu, Yi-Nan;Tsai, Meng-Feng;Tsai, Tzu-Hsiu;Yu, Chong-Jen;Yang, James Chih-Hsin;Yang, Pan-Chyr; Chen, Y.-F. and Hsieh, M.-S. and Wu, S.-G. and Chang, Y.-L. and Shih, J.-Y. and Liu, Y.-N. and Tsai, M.-F. and Tsai, T.-H. and Yu, C.-J. and Yang, J.C.-H. and Yang, P.-C.; 楊志新;張逸良;楊泮池;余忠仁;謝明書;吳尚俊;陳瑛芳;蔡子修;施金元; 楊志新;張逸良;楊泮池;余忠仁;謝明書;吳尚俊;陳瑛芳;蔡子修;施金元; MIN-SHU HSIEH; Chen, Yen-Fu; Hsieh, Min-Shu; YIH-LEONG CHANG; Wu, Shang-Gin; CHONG-JEN YU; JIN-YUAN SHIH; Chang, Yih-Leong; CHIH-HSIN YANG; Shih, Jin-Yuan; Liu, Yi-Nan; Tsai, Meng-Feng; Tsai, Tzu-Hsiu; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, Pan-Chyr |
| 臺大學術典藏 |
2018-09-10T09:41:46Z |
Survival of lung adenocarcinoma patients with malignant pleural effusion
|
楊泮池; Wu, S.-G. and Yu, C.-J. and Tsai, M.-F. and Liao, W.-Y. and Yang, C.-H. and Jan, I.-S. and Yang, P.-C. and Shih, J.-Y.; Wu, Shang-Gin;Yu, Chong-Jen;Tsar, Meng-Feng;Liao, Wei-Yu;Yang, Chih-Hsin;Jan, I-Shiow;Yang, Pan-Chyr;Shin, Jin-Yuan; 楊志新 ;詹一秀 ;楊泮池 ;廖唯昱 ;余忠仁; 楊志新 ;詹一秀 ;楊泮池 ;廖唯昱 ;余忠仁; Wu, Shang-Gin; WEI-YU LIAO; Wu, Shang-Gin; Chong-Jen Yu; Yu, Chong-Jen; Yu, Chong-Jen; Tsar, Meng-Feng; JIN-YUAN SHIH; Liao, Wei-Yu; Liao, Wei-Yu; I-SHIOW JAN; Yang, Chih-Hsin; Yang, Chih-Hsin; Jan, I-Shiow; Jan, I-Shiow; Yang, Pan-Chyr; Yang, Pan-Chyr; Shin, Jin-Yuan |
| 臺大學術典藏 |
2018-09-10T09:15:12Z |
Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin
|
Chang, Yeun-Chung; Yu, Chong-Jen; Chen, Chung-Ming; Hu, Fu-Chang; Hsu, Hao-Hsiang; Tseng, Wen-Yih I.; Shih, Tiffany Ting-Fang; Yang, Pan-Chyr; Yang, James Chih-Hsin曾文毅; 楊志新; 陳中明; 張允中; 施庭芳; 楊泮池; 余忠仁; 胡賦強; 曾文毅; 楊志新; 陳中明; 張允中; 施庭芳; 楊泮池; 余忠仁; 胡賦強Chang, Y.-C.; Yu, C.-J.; Chen, C.-M.; Hu, F.-C.; Hsu, H.-H.; Tseng, W.-Y.I.; Ting-Fang Shih, T.; Yang, P.-C.; Chih-Hsin Yang, J.; 楊泮池; Chang, Yeun-Chung; TIFFANY TING-FANG SHIH; Yu, Chong-Jen; Chen, Chung-Ming; CHONG-JEN YU; Yang, Pan-Chyr |
| 臺大學術典藏 |
2018-09-10T09:13:20Z |
EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR
|
JIN-YUAN SHIH; Chang, Yih-Leong; Shih, Jin-Yuan; Chen, Ya-Hui; Tsai, Meng-Feng; Yu, Chong-Jen; Yang, Chih-Hsin; Yang, Pan-Chyr; 陳盈憲; Wu, S.-G. and Kuo, Y.-W. and Chang, Y.-L. and Shih, J.-Y. and Chen, Y.-H. and Tsai, M.-F. and Yu, C.-J. and Yang, C.-H. and Yang, P.-C.; Wu, Shang-Gin;Kuo, Yao-Wen;Chang, Yih-Leong;Shih, Jin-Yuan;Chen, Ya-Hui;Tsai, Meng-Feng;Yu, Chong-Jen;Yang, Chih-Hsin;Yang, Pan-Chyr; 楊志新 ;張逸良 ;楊泮池 ;余忠仁 ;郭耀文 ;吳尚俊 ;施金元 ;陳盈憲; YIH-LEONG CHANG; Wu, Shang-Gin; Kuo, Yao-Wen; Chong-Jen Yu |
| 臺大學術典藏 |
2018-09-10T09:13:19Z |
Advanced non-small cell lung cancer in patients aged 45 years or younger: Outcomes and prognostic factors
|
Hsu, Chia-Lin;Chen, Kuan-Yu;Shih, Jin-Yuan;Ho, Chao-Chi;Yang, Chih-Hsin;Yu, Chong-Jen;Yang, Pan-Chyr; Hsu, C.-L. and Chen, K.-Y. and Shih, J.-Y. and Ho, C.-C. and Yang, C.-H. and Yu, C.-J. and Yang, P.-C.; 楊志新 ;楊泮池 ;許嘉林 ;陳冠宇 ;余忠仁 ;何肇基 ;施金元; Chong-Jen Yu; Hsu, Chia-Lin; Chen, Kuan-Yu; CHIA-LIN HSU; CHAO-CHI HO; Shih, Jin-Yuan; JIN-YUAN SHIH; Ho, Chao-Chi; Yang, Chih-Hsin; Yu, Chong-Jen; Yang, Pan-Chyr |
| 臺大學術典藏 |
2018-09-10T06:48:43Z |
Recurrent advancing wavelike epitheliopathy from the opposite side of the initial presentation
|
FUNG-RONG HU; Chu, HS; Wu, Shang-Gin; I-JONG WANG; Hu, FR; Chang, Yih-Leong; Wang, IJ; Shih, Jin-Yuan; Hou, YC; Chen, WL.; Liu, Yi-Nan; Tsai, Meng-Feng; Tsai, Tzu-Hsiu; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, Pan-Chyr; 楊志新; 張逸良; 楊泮池; 余忠仁; 謝明書; 吳尚俊; 陳瑛芳; 蔡子修; 施金元; Hsieh, Min-Shu; Chen, Yen-Fu; WEI-LI CHEN; Huang, YH; HUANG, YU-HSUN;CHU, HSIAO-SANG;HU, FUNG -RONG;WANG, I-JONG;HOU, YU-CHI;CHEN, WEI-LI; 黃昱勳;朱筱桑;胡芳蓉;王一中;侯鈺琪;陳偉勵; Huang, Y.-H. and Chu, H.-S. and Hu, F.-R. and Wang, I.-J. and Hou, Y.-C. and Chen, W.-L.; Huang, YH;Chu, HS;Hu, FR;Wang, IJ;Hou, YC;Chen, WL. |
| 國立成功大學 |
2018 |
以溝通指引落實癌症臨床試驗知情同意並提升病人自主決策能力：瞭解影響因素、指引建立與評價成效
|
高綺吟;黃美智;蘇五洲;胡文郁;楊志新;方素瓔 |
| 國立臺灣大學 |
2016 |
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients
|
Wu, Shang-Gin; Liu, Yi-Nan; Tsai, Meng-Feng; Chang, Yih-Leong; Yu, Chong-Jen; Yang, Pan-Chyr; Yang, James Chih-Hsin; Wen, Yueh-Feng; Shih, Jin-Yuan; 楊志新; 張逸良; 楊泮池; 余忠仁; 溫岳峰; 吳尚俊; 施金元 |
| 國立臺灣大學 |
2016 |
Efficacy of of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion-Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian Populations
|
Chen, Yen-Fu; Hsieh, Min-Shu; Wu, Shang-Gin; Chang, Yih-Leong; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, Pan-Chyr; Shih, Jin-Yuan; 楊志新; 張逸良; 楊泮池; 余忠仁; 謝明書; 吳尚俊; 陳瑛芳; 施金元 |
| 國立臺灣大學 |
2016 |
Update on recent preclinical and clinical studies of T790M mutant-specific irreversible epidermal growth factor receptor tyrosine kinase inhibitors
|
Liao, Bin-Chi; Lin, Chia-Chi; Lee, Jih-Hsiang; Yang, James Chih-Hsin; 林家齊; 楊志新; 廖斌志; 李日翔 |
| 國立臺灣大學 |
2016 |
Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis
|
Chen, Li-Yang; Molina-Vila, Miguel A.; Ruan, Sheng-Yuan; Su, Kang-Yi; Liao, Wei-Yu; Yu, Kai-Lun; Ho, Chao-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Yang, James Chih-Hsin; Rosell, Rafael; Yang, Pan-Chyr; 楊志新; 蘇剛毅; 廖唯昱; 余忠仁; 何肇基; 阮聖元; 施金元 |
| 國立臺灣大學 |
2016 |
Safety of gefitinib in non-small cell lung cancer treatment
|
Hsiue, Emily Han-Chung; Lee, Jih-Hsiang; Lin, Chia-Chi; Yang, James Chih-Hsin; 林家齊; 楊志新; 李日翔 |
| 國立臺灣大學 |
2016 |
Time to response in patients with ALK plus NSCLC receiving alectinib in the phase II NP28673 and NP28761 studies
|
Gandhi, L.; Gadgeel, S.; Shaw, A.; Barlesi, F.; Crino, L.; Yang, J. C-H.; Dingemans, A-M. C.; Kim, D-W.; de Marinis, F.; Schulz, M.; Liu, S.; Fish, S.; Kotb, A.; Ou, S-H. I.; 楊志新 |
| 國立臺灣大學 |
2016 |
Cytotoxic Chemotherapy as First-Line Therapy for Advanced Non-Small-Cell Lung Cancer in Taiwan: Daily Practice
|
Liang, Yi-Hsin; Shao, Yu-Yun; Liao, Bin-Chi; Lee, Ho-Sheng; Yang, James Chih-Hsin; Chen, Ho-Min; Chiang, Chun-Ju; Cheng, Ann-Lii; Lai, Mei-Shu; 梁逸歆; 楊志新; 邵幼雲; 廖斌志; 賴美淑; 鄭安理 |
| 國立臺灣大學 |
2016 |
Anaplastic Lymphoma Kinase (ALK) Kinase Domain Mutation Following ALK Inhibitor(s) Failure in Advanced ALK Positive Non-Small-Cell Lung Cancer: Analysis and Literature Review
|
Lin, Yen-Ting; Yu, Chong-Jen; Yang, James Chih-Hsin; Shih, Jin-Yuan; 楊志新; 余忠仁; 林奕廷; 林怡岑; 施金元 |
| 國立臺灣大學 |
2016 |
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial
|
Schuler, M.; Yang, J. C. -H.; Park, K.; Kim, J. -H.; Bennouna, J.; Chen, Y. -M.; Chouaid, C.; De Marinis, F.; Feng, J. -F.; Grossi, F.; Kim, D. -W.; Liu, X.; Lu, S.; Strausz, J.; Vinnyk, Y.; Wiewrodt, R.; Zhou, C.; Wang, B.; Chand, V. K.; Planchard, D.; 楊志新 |
| 國立臺灣大學 |
2016 |
Profile of the therascreen (R) EGFR RGQ PCR kit as a companion diagnostic for gefitinib in non-small cell lung cancer
|
Hsiue, Emily Han-Chung; Lee, Jih-Hsiang; Lin, Chia-Chi; Yang, James Chih-Hsin; 林家齊; 楊志新; 李日翔 |
| 臺大學術典藏 |
2016 |
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial
|
Schuler, M.;Yang, J. C. -H.;Park, K.;Kim, J. -H.;Bennouna, J.;Chen, Y. -M.;Chouaid, C.;De Marinis, F.;Feng, J. -F.;Grossi, F.;Kim, D. -W.;Liu, X.;Lu, S.;Strausz, J.;Vinnyk, Y.;Wiewrodt, R.;Zhou, C.;Wang, B.;Chand, V. K.;Planchard, D.; 楊志新; Schuler, M.; Yang, J. C. -H.; Park, K.; Kim, J. -H.; Bennouna, J.; Chen, Y. -M.; Chouaid, C.; De Marinis, F.; Feng, J. -F.; Grossi, F.; Kim, D. -W.; Liu, X.; Lu, S.; Strausz, J.; Vinnyk, Y.; Wiewrodt, R.; Zhou, C.; Wang, B.; Chand, V. K.; Planchard, D. |
| 國立臺灣大學 |
2015 |
High Prevalence of the BIM Deletion Polymorphism in Young Female Breast Cancer in an East Asian Country
|
Lin, Ching-Hung; Shen, Chen-Yang; Lee, Jih-Hsiang; Huang, Chiun-Sheng; Yang, Chih-Hsin; Kuo, Wen-Hung; Chang, Dwan-Ying; Hsiung, Chia-Ni; Kuo, Kuan-Ting; Chen, Wei-Wu; Chen, I-Chun; Wu, Pei-Fang; Kuo, Sung-Hsin; Chen, Chien-Jen; Lu, Yen-Shen; Cheng, Ann-Lii; 林志弘; 楊志新; 陳偉武; 郭文宏; 盧彥伸; 林璟宏; 陳怡君; 郭冠廷; 郭頌鑫; 吳佩芳; 鄭安理; 黃俊升; 張端瑩; 李日翔; 林季宏 |
| 國立臺灣大學 |
2015 |
Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion
|
Tsai, Tzu-Hsiu; Wu, Shang-Gin; Hsieh, Min-Shu; Yu, Chong-Jen; Yang, James Chih-Hsin; Shih, Jin-Yuan; 楊志新; 余忠仁; 謝明書; 吳尚俊; 蔡子修; 施金元 |
| 國立臺灣大學 |
2015 |
Rhodomycin A, a novel Src-targeted compound, can suppress lung cancer cell progression via modulating Src-related pathways
|
Lai, Yi-Hua; Chen, Min-Hsuan; Lin, Sih-Yin; Lin, Sheng-Yi; Wong, Yung-Hao; Yu, Sung-Liang; Chen, Huei-Wen; Yang, Chih-Hsin; Chang, Gee-Chen; Chen, Jeremy J. W.; 楊志新; 俞松良; 陳惠文 |
| 國立臺灣大學 |
2015 |
Comparative Effectiveness of First-Line Platinum-Based Chemotherapy Regimens for Advanced Lung Squamous Cell Carcinoma
|
Liao, Bin-Chi; Shao, Yu-Yun; Chen, Ho-Min; Shau, Wen-Yi; Lin, Zhong-Zhe; Kuo, Raymond Nienchen; Lai, Chiu-Ling; Chen, Kuo-Hsing; Cheng, Ann-Lii; Yang, James Chih-Hsin; Lai, Mei-Shu; 楊志新; 邵幼雲; 廖斌志; 賴美淑; 林宗哲; 鄭安理; 郭年真; 陳國興 |
| 國立臺灣大學 |
2015 |
Advanced non-small cell lung cancer in the elderly: The impact of age and comorbidities on treatment modalities and patient prognosis
|
Hsu, Chia-Lin; Chen, Jen-Hau; Chen, Kuan-Yu; Shih, Jin-Yuan; Yang, James Chih-Hsin; Yu, Chong-Jen; Yang, Pan-Chyr; 楊志新; 楊泮池; 許嘉林; 陳冠宇; 余忠仁; 陳人豪; 施金元 |
| 國立臺灣大學 |
2015 |
Pemetrexed Continuation Maintenance in Patients with Nonsquamous Non-small Cell Lung Cancer: Review of Two East Asian Trials in Reference to PARAMOUNT
|
Yang, James Chin-Hsin; Ahn, Myung-Ju; Nakagawa, Kazuhiko; Tamura, Tomohide; Barraclough, Helen; Enatsu, Sotaro; Cheng, Rebecca; Orlando, Mauro; 楊志新 |
| 國立臺灣大學 |
2015 |
First-in-human phase I study of EGF816, a third generation, mutant-selective EGFR tyrosine kinase inhibitor, in advanced non-small cell lung cancer (NSCLC) harboring T790M.
|
Tan, Daniel Shao-Weng; Seto, Takashi; Leighl, Natasha B.; Riely, Gregory J.; Sequist, Lecia V.; Felip, Enriqueta; Wolf, Juergen; Yang, James Chih-Hsin; Matushansky, Igor; Yu, Xiaolu; Schmitz, Shu-Fang Hsu; Cui, Xiaoming; Kim, Dong-Wan; 楊志新 |
| 國立臺灣大學 |
2015 |
How to use afatinib in clinical practice
|
Yang, James Chih-Hsin; 楊志新 |
| 國立臺灣大學 |
2015 |
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer
|
Liu, Yi-Nan; Chang, Tzu-Hua; Tsai, Meng-Feng; Wu, Shang-Gin; Tsai, Tzu-Hsiu; Chen, Hsuan-Yu; Yu, Sung-Liang; Yang, James Chih-Hsin; Shih, Jin-Yuan; 楊志新; 俞松良; 吳尚俊; 蔡子修; 施金元 |
| 國立臺灣大學 |
2015 |
Influence of dose adjustment on afatinib safety and efficacy in patients (pts) with advanced EGFR mutation-positive (EGFRm plus ) non-small cell lung cancer (NSCLC).
|
Yang, James Chih-Hsin; Ahn, Myung-Ju; Dickgreber, Nicolas J.; Halmos, Balazs; Hirsh, Vera; Hochmair, Maximilian J.; Levy, Benjamin Philip; De Marinis, Filippo; Mok, Tony; O'Byrne, Kenneth; Okamoto, Isamu; Schuler, Martin H.; Sebastian, Martin; Shah, Riyaz N. H.; Tan, Eng-Huat; Yamamoto, Nobuyuki; Marten, Angela; Massey, Dan; Wind, Sven; Carbone, David Paul; 楊志新 |
| 國立臺灣大學 |
2015 |
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
|
Yang, James Chih-Hsin; Wu, Yi-Long; Schuler, Martin; Sebastian, Martin; Popat, Sanjay; Yamamoto, Nobuyuki; Zhou, Caicun; Hu, Cheng-Ping; O'Byrne, Kenneth; Feng, Jifeng; Lu, Shun; Huang, Yunchao; Geater, Sarayut L.; Lee, Kye Young; Tsai, Chun-Ming; Gorbunova, Vera; Hirsh, Vera; Bennouna, Jaafar; Orlov, Sergey; Mok, Tony; Boyer, Michael; Su, Wu-Chou; Lee, Ki Hyeong; Kato, Terufumi; Massey, Dan; Shahidi, Mehdi; Zazulina, Victoria; Sequist, Lecia V.; 楊志新 |
| 國立臺灣大學 |
2015 |
Maintenance therapy with gefitinib (G)/pemetrexed (P) versus P alone after induction therapy with P/platinum for metastatic lung adenocarcinoma (MLADC) harboring no sensitizing epidermal growth factor receptor mutation (sEGFRm): A phase II multicenter randomized open-label study (GENIUS trial).
|
Tsai, Chun-Ming; Lai, Chun-Liang; Chiu, Chao-Hua; Hsia, Te-Chun; Chen, Chen-Hsin; Chang, Gee-Chen; Shih, Jin-Yuan; Ho, Ching-Liang; Chen, Yuh-Min; Yang, James Chih-Hsin; 楊志新; 施金元 |
| 國立臺灣大學 |
2015 |
Chloroquine Enhances Gefitinib Cytotoxicity in Gefitinib-Resistant Nonsmall Cell Lung Cancer Cells
|
Tang, Mei-Chuan; Wu, Mei-Yi; Hwang, Ming-Hung; Chang, Ya-Ting; Huang, Hui-Ju; Lin, Anya Maan-Yuh; Yang, James Chih-Hsin; 楊志新 |
| 國立臺灣大學 |
2015 |
A randomized Phase 3 study comparing first-line pemetrexed plus cisplatin followed by gefitinib maintenance (PC/G) with gefitinib monotherapy (G) in East Asian patients (pts) with locally advanced or metastatic nonsquamous non-small cell lung cancer (nSqNSCLC): Final survival results.
|
Yang, James Chih-Hsin; Srimuninnimit, Vichien; Ahn, Myung-Ju; Lin, Chia-Chi; Kim, Sang-We; Tsai, Chun-Ming; Mok, Tony; Orlando, Mauro; Puri, Tarun; Wang, Xin; Park, Keunchil; 林家齊; 楊志新 |
| 國立臺灣大學 |
2015 |
Epidermal growth factor receptor tyrosine kinase inhibitors on clinical outcome of advanced non-small cell lung cancer patients with leptomeningeal carcinomatosis.
|
Liao, Bin-Chi; Lee, Jih-hsiang; Lin, Chia-Chi; Ho, Chao-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Yang, James Chih-Hsin; 林家齊; 楊志新; 廖斌志; 余忠仁; 何肇基; 施金元; 李日翔 |
| 國立臺灣大學 |
2015 |
Impact of Specific Epidermal Growth Factor Receptor (EGFR) Mutations and Clinical Characteristics on Outcomes After Treatment With EGFR Tyrosine Kinase Inhibitors Versus Chemotherapy in EGFR-Mutant Lung Cancer: A Meta-Analysis
|
Lee, Chee Khoon; Wu, Yi-Long; Ding, Pei Ni; Lord, Sarah J.; Inoue, Akira; Zhou, Caicun; Mitsudomi, Tetsuya; Rosell, Rafael; Pavlakis, Nick; Links, Matthew; Gebski, Val; Gralla, Richard J.; Yang, James Chih-Hsin; 楊志新 |
| 國立臺灣大學 |
2015 |
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6
|
Yang, James C-H; Sequist, Lecia V.; Geater, Sarayut Lucien; Tsai, Chun-Ming; Mok, Tony Shu Kam; Schuler, Martin; Yamamoto, Nobuyuki; Yu, Chong-Jen; Ou, Sai-Hong I.; Zhou, Caicun; Massey, Daniel; Zazulina, Victoria; Wu, Yi-Long; 楊志新; 余忠仁 |
| 國立臺灣大學 |
2015 |
Preliminary results of TATTON, a multi-arm phase Ib trial of AZD9291 combined with MEDI4736, AZD6094 or selumetinib in EGFR-mutant lung cancer.
|
Oxnard, Geoffrey R.; Ramalingam, Suresh S.; Ahn, Myung-Ju; Kim, Sang-We; Yu, Helena Alexandra; Saka, Hideo; Horn, Leora; Goto, Koichi; Ohe, Yuichiro; Cantarini, Mireille; Frewer, Paul; Lahn, Michael; Yang, James Chih-Hsin; 楊志新 |
| 國立臺灣大學 |
2015 |
AZD3759, an EGFR inhibitor with blood brain barrier (BBB) penetration for the treatment of non-small cell lung cancer (NSCLC) with brain metastasis (BM): Preclinical evidence and clinical cases.
|
Kim, Dong-Wan; Yang, James Chih-Hsin; Chen, Kan; Cheng, Ziqiang; Yin, Lucy; Martin, Paul David; Yang, Zhenfan; Jiang, Haiyi; Ahn, Myung-Ju; 楊志新 |
| 國立臺灣大學 |
2015 |
TIGER-3: A phase 3, open-label, randomized study of rociletinib vs cytotoxic chemotherapy in patients (pts) with mutant EGFR non-small cell lung cancer (NSCLC) progressing on prior EGFR TKI therapy and doublet chemotherapy.
|
Yang, James Chih-Hsin; Popat, Sanjay; Georgiou, Panos; Miyamoto, Emiko; Isaacson, Jeffrey D.; Wakelee, Heather A.; 楊志新 |
| 國立臺灣大學 |
2015 |
The Prognostic Impact of Type 2 Diabetes Mellitus on Early Cervical Cancer in Asia
|
Kuo, Hung-Yang; Lin, Zhong-Zhe; Kuo, Raymond; Shau, Wen-Yi; Lai, Chiu-Lin; Yang, Yen-Yun; Shao, Yu-Yun; Hsu, Chiun; Cheng, Wen-Fan; Cheng, Ann-Lii; Yang, James Chih-Hsin; Lai, Mei-Shu; 郭漢岳; 郭弘揚; 鄭文芳; 楊志新; 邵幼雲; 賴美淑; 林宗哲; 鄭安理; 許駿 |
| 國立臺灣大學 |
2015 |
The Response, Outcome and Toxicity of Aggressive Palliative Thoracic Radiotherapy for Metastatic Non-Small Cell Lung Cancer Patients with Controlled Extrathoracic Diseases
|
Chiang, Yun; Yang, James Chih-Hsin; Hsu, Feng-Ming; Chen, Yu-Hsuan; Shih, Jin-Yuan; Lin, Zhong-Zhe; Lan, Keng-Hsueh; Cheng, Ann-Lii; Kuo, Sung-Hsin; 楊志新; 郭頌鑫; 鄭安理; 陳育瑄; 藍耿學; 施金元; 許峰銘 |
| 國立臺灣大學 |
2015 |
Second and third-generation epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancer
|
Liao, Bin-Chi; Lin, Chia-Chi; Yang, James Chih-Hsin; 林家齊; 楊志新; 廖斌志 |
| 國立臺灣大學 |
2015 |
The impact on overall survival (OS) of first-line gefitinib (G) and erlotinib (E) and of clinical factors in advanced non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor mutations (EGFR mut) based on meta-analysis of 1,231 patients (pts) enrolled in 6 major randomized trials.
|
Lee, Chee; Davies, Lucy Claire; Wu, Yi-Long; Mitsudomi, Tetsuya; Inoue, Akira; Rosell, Rafael; Zhou, Caicun; Nakagawa, Kazuhiko; Throngprasert, Sumitra; Fukuoka, Masahiro; Gralla, Richard J.; Gebski, Val; Mok, Tony; Yang, James Chih-Hsin; 楊志新 |
| 國立臺灣大學 |
2015 |
Treating patients with ALK-positive non-small cell lung cancer: latest evidence and management strategy
|
Liao, Bin-Chi; Lin, Chia-Chi; Shih, Jin-Yuan; Yang, James Chih-Hsin; 林家齊; 楊志新; 廖斌志; 施金元 |
| 國立臺灣大學 |
2015 |
Pembrolizumab (pembro; MK-3475) plus platinum doublet chemotherapy (PDC) as front-line therapy for advanced non-small cell lung cancer (NSCLC): KEYNOTE-021 Cohorts A and C.
|
Papadimitrakopoulou, Vassiliki; Patnaik, Amita; Borghaei, Hossein; Stevenson, James; Gandhi, Leena; Gubens, Matthew A.; Yang, James Chih-Hsin; Sequist, Lecia V.; Ge, Joy Yang; Bourque, Jennifer; Bachman, Robert D.; Im, Ellie; Gadgeel, Shirish M.; 楊志新 |
| 國立臺灣大學 |
2015 |
Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation- positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial
|
Soria, Jean-Charles; Wu, Yi-Long; Nakagawa, Kazuhiko; Kim, Sang-We; Yang, Jin-Ji; Ahn, Myung-Ju; Wang, Jie; Yang, James Chih-Hsin; Lu, You; Atagi, Shinji; Ponce, Santiago; Lee, Dae Ho; Liu, Yunpeng; Yoh, Kiyotaka; Zhou, Jian-Ying; Shi, Xiaojin; Webster, Alan; Jiang, Haiyi; Mok, Tony S. K.; 楊志新 |
| 國立臺灣大學 |
2015 |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis
|
Liao, Bin-Chi; Lee, Jih-Hsiang; Lin, Chia-Chi; Chen, Ya-Fang; Chang, Chin-Hao; Ho, Chao-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Yang, James Chih-Hsin; 林家齊; 楊志新; 廖斌志; 陳雅芳; 余忠仁; 何肇基; 施金元; 李日翔; 張晉豪 |
顯示項目 11-60 / 209 (共5頁)
1 2 3 4 5 > >>
每頁顯示[10|25|50]項目
|
